{"name": "Atritech",
 "permalink": "atritech",
 "crunchbase_url": "http://www.crunchbase.com/company/atritech",
 "homepage_url": "http://www.atritech.net/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "hardware",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "questions@atritech.net",
 "phone_number": "763.258.0250",
 "description": "",
 "created_at": "Thu Jan 20 06:45:55 UTC 2011",
 "updated_at": "Thu Jan 20 06:45:54 UTC 2011",
 "overview": "\u003Cp\u003EAtritech is a private company located in Minneapolis, Minnesota.  The company was founded in 2000 and has developed proprietary technology focused on replacing long term anticoagulation therapy for patients with non-valvular atrial fibrillation at risk of stroke.  The first implants of the WATCHMAN\u00c2\u00ae Left Atrial Appendage Closure Technology  were performed in Germany in August of 2002 and in the United States in October of 2003.  Since then the company has conducted a large randomized clinical trial comparing the WATCHMAN\u00c2\u00ae Left Atrial Appendage Closure Technology to long term Warfarin therapy in patients with non-valvular atrial fibrillation at risk of stroke. The WATCHMAN\u00c2\u00ae Device is CE Marked and available in many markets outside the United States. The WATCHMAN\u00c2\u00ae Device is currently available For Investigational Use Only in the United States.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       101],
      "assets/images/resized/0011/8165/118165v1-max-150x150.jpg"],
     [[224,
       151],
      "assets/images/resized/0011/8165/118165v1-max-250x250.jpg"],
     [[224,
       151],
      "assets/images/resized/0011/8165/118165v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Jim",
      "last_name": "Bullock",
      "permalink": "jim-bullock",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": 375000000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32\u0026aid=DJFVW00020110119e71k000rt\u0026r=Rss\u0026s=DJFVW",
   "source_description": "\t  Boston Scientific To Acquire Device Maker Atritech For Up To $375M",
   "acquired_year": 2011,
   "acquired_month": 1,
   "acquired_day": 20,
   "acquiring_company":
    {"name": "Boston Scientific",
     "permalink": "boston-scientific",
     "image":
      {"available_sizes":
        [[[150,
           66],
          "assets/images/resized/0006/0732/60732v2-max-150x150.png"],
         [[151,
           67],
          "assets/images/resized/0006/0732/60732v2-max-250x250.png"],
         [[151,
           67],
          "assets/images/resized/0006/0732/60732v2-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "3750 Annapolis Lane",
    "address2": "Suite 105",
    "zip_code": "55447",
    "city": "Plymouth",
    "state_code": "MN",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}